Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Genotyping Assay Market Growth in 2025?

The market volume of the genotyping assay has witnessed robust expansion in recent times. Forecasted to escalate from $33.98 billion in 2024 to a stunning $41.6 billion in 2025, it displays a compound annual growth rate (CAGR) of 22.4%. Factors such as the utilization of conventional glassware, cultural and lifestyle impacts, economic elements, the boom in the hospitality and foodservice industry, alongside trending gifts and decor, have significantly contributed to the growth during the historic period.

What Is the Forecast for the Genotyping Assay Market Size Through 2029?

The market size for genotyping assays is predicted to observe substantial expansion in the forthcoming years, escalating to $95.5 billion in 2029 with a compound annual growth rate (CAGR) of 23.1%. The progression in the predicted span is credited to elements such as customization and personalization, health and wellness tendencies, the rise of e-commerce, intelligent and functional glassware, along with culinary and mixology trends. Noteworthy trends during the projection period comprise of material innovation, imaginative shapes, and designs, intelligent glassware, specialized glassware for drinks, and health and safety facets.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13444&type=smp

What are the Key Market Players in Genotyping Assay Market and How They’re Evolving?

Major companies operating in the genotyping assay market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv Inc., Promega Corporation, Luminex Corporation, Integrated DNA Technologies Inc., Integrated DNA Technologies Ltd., Sequenom Inc., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies PLC, GenMark Diagnostics Inc., Macrogen Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Genewiz Inc., New England Biolabs, TrimGen Corporation, Xcelris Genomics

What Are the Primary Growth Drivers in the Genotyping Assay Market?

The surge in the prevalence of genetic disorders is predicted to fuel the genotyping assay market’s expansion. Genetic disorders, defined as medical conditions caused by abnormalities or mutations in an individual’s DNA, significantly influence the use of genotyping assays. These assessments allow for comparisons between the DNA of ailing individuals and the DNA of healthy ones, helping to identify specific mutations or variations associated with a particular genetic disorder. Gene People, a UK-based charity supporting those with genetic conditions, reported in June 2023 that one in every 25 UK children has a genetic disorder. This equates to nearly 30,000 newborns and young children, in addition to over 2.4 million children and adults yearly. Consequently, the increased prevalence of genetic disorders is fuelling the expansion of the genotyping assay market. The genotyping assay market is expected to see further growth due to a burgeoning demand for personalized medicine. Personalized medicine adapts medical treatments to a person’s unique genetic composition, thereby offering more precise and effective healthcare interventions. Genotype assays play a critical role in personalised medicine, as they analyze an individual’s genetic makeup to customize medical treatments, drug selection, and dosages. In January 2023, for example, the US-based federal agency, the Food and Drug Administration, reported that the Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Of these 35 therapeutic NMEs, approximately 34% (or 12 of them) are considered personalized medicines according to the Personalized Medicine Coalition (PMC). Therefore, the increasing demand for personalized medicine is a significant driver of the genotyping assay market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13444&type=smp

What Are the Leading Segments in the Global Genotyping Assay Industry?

The genotyping assay market covered in this report is segmented –

1) By Product And Service: Reagents And Kits, Genotyping Services, Instruments, Bioinformatics

2) By Technology: Microarrays, Polymerase Chain Reaction, Sequencing, Capillary Electrophoresis, Matrix-assisted Laser Desorption Or Ionization-Time Of Flight Mass Spectrometry, Other Technologies

3) By End-User: Pharmacogenomics, Personalized Medicine And Diagnostics, Animal Genetics, Agricultural Biotechnology, Research And Diagnostic Laboratories, Academic Institutes

Subsegments:

1) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits, Genotyping Services, Genotyping by PCR, Whole Genome Sequencing Services, SNP Genotyping Services

2) By Instruments: PCR Machines, Sequencing Instruments, Microarrays

3) By Bioinformatics: Data Analysis Software, Genotyping Data Management Tools

What Are the Key Market Trends in the Genotyping Assay Industry?

Leading corporations in the genotyping assay industry are innovating in the field of genomic research, particularly with the development of CE-IVD marked assays that can identify treatment-resistant HIV-1 strains. The CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit, based on Sanger sequencing, is one such innovation that allows the inspection of HIV positive samples in the quest for genetic variants that may have resistance to standard antiretroviral drugs. For example, Thermo Fisher Scientific, an American company, introduced the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit in January 2023. This kit possesses the capability to discover resistant HIV-1 strains and offers distinguishing features such as the evaluation of genomic mutations, leveraging HIV RNA, identifying drug resistance mutations, and the application of the gold-standard Sanger sequencing technology. Furthermore, it is designed for clinical arenas. The introduction of the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit has amplified its value by enhancing the discovery of stubborn HIV-1 strains and offering simple-to-use controls and reagents. In addition, it satisfies regulatory demands, showcases superior performance capabilities, and easily integrates with already existing sequencing platforms and procedures.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

What Is the Regional Outlook for the Genotyping Assay Market?

North America was the largest region in the genotyping assay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genotyping assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13444

This Report Delivers Insight On:

1. How big is the genotyping assay market, and how is it changing globally?

2. Who are the major companies in the genotyping assay market, and how are they performing?

3. What are the key opportunities and risks in the genotyping assay market right now?

4. Which products or customer segments are growing the most in the genotyping assay market?

5. What factors are helping or slowing down the growth of the genotyping assay market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model